TipRanks on MSN

Dynavax, Inhibikase and more: Stocks trending by analysts

Unless such surprises materialize, analysts like Phipps see the Dynavax story as largely written, with most of the remaining upside and downside bounded by Sanofi’s $15.50 per share offer. Inhibikase ...

Best Weight Loss Patches and GLP-1 Patch Options: OzemPatches Examined as FDA Approves Once-Daily Wegovy Pill for Chronic Weight Management

Herbal Transdermal Wellness Patch Category Examined as Consumers Compare Prescription GLP-1 Costs With Non-Prescription ...